MedWatch

Nuheara and HP collaboration hearing aid approved for OTC channel

Australia-based Nuheara is throwing its hat into the ring and has prepared a product for the US over-the-counter market alongside HP.

Photo: Charlie Riedel/AP/Ritzau Scanpix

Nuheara is ready to enter the brand new over-the-counter (OTC) market for hearing aids in the US after being given the green light by the FDA for its HP Hearing Pro device.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs